User profiles for Jan J Molenaar
Jan Molenaar- Verified email at prinsesmaximacentrum.nl Cited by 9985 |
[HTML][HTML] The landscape of genomic alterations across childhood cancers
…, J Schulte, R Siebert, F Westermann, JJ Molenaar… - Nature, 2018 - nature.com
Pan-cancer analyses that examine commonalities and differences among various cancer
types have emerged as a powerful way to obtain novel insights into cancer biology. Here we …
types have emerged as a powerful way to obtain novel insights into cancer biology. Here we …
[HTML][HTML] Sequencing of neuroblastoma identifies chromothripsis and defects in neuritogenesis genes
Neuroblastoma is a childhood tumour of the peripheral sympathetic nervous system. The
pathogenesis has for a long time been quite enigmatic, as only very few gene defects were …
pathogenesis has for a long time been quite enigmatic, as only very few gene defects were …
[HTML][HTML] Genome sequencing of pediatric medulloblastoma links catastrophic DNA rearrangements with TP53 mutations
Genomic rearrangements are thought to occur progressively during tumor development.
Recent findings, however, suggest an alternative mechanism, involving massive chromosome …
Recent findings, however, suggest an alternative mechanism, involving massive chromosome …
Relapsed neuroblastomas show frequent RAS-MAPK pathway mutations
… In the version of this article initially published online, affiliation 30 stating that "These authors
jointly supervised this work" was incorrectly omitted for author Jan J. Molenaar. The error …
jointly supervised this work" was incorrectly omitted for author Jan J. Molenaar. The error …
Neuroblastoma is composed of two super-enhancer-associated differentiation states
Neuroblastoma and other pediatric tumors show a paucity of gene mutations, which has
sparked an interest in their epigenetic regulation. Several tumor types include phenotypically …
sparked an interest in their epigenetic regulation. Several tumor types include phenotypically …
LIN28B induces neuroblastoma and enhances MYCN levels via let-7 suppression
JJ Molenaar, R Domingo-Fernández, ME Ebus… - Nature …, 2012 - nature.com
LIN28B regulates developmental processes by modulating microRNAs (miRNAs) of the let-7
family. A role for LIN28B in cancer has been proposed but has not been established in vivo. …
family. A role for LIN28B in cancer has been proposed but has not been established in vivo. …
TERT rearrangements are frequent in neuroblastoma and identify aggressive tumors
…, RE George, GAM Tytgat, JJ Molenaar… - Nature …, 2015 - nature.com
Whole-genome sequencing detected structural rearrangements of TERT in 17 of 75 high-stage
neuroblastomas, with five cases resulting from chromothripsis. Rearrangements were …
neuroblastomas, with five cases resulting from chromothripsis. Rearrangements were …
[HTML][HTML] An organoid biobank for childhood kidney cancers that captures disease and tissue heterogeneity
…, MM van den Heuvel-Eibrink, JJ Molenaar… - Nature …, 2020 - nature.com
Kidney tumours are among the most common solid tumours in children, comprising distinct
subtypes differing in many aspects, including cell-of-origin, genetics, and pathology. Pre-…
subtypes differing in many aspects, including cell-of-origin, genetics, and pathology. Pre-…
Functional MYCN signature predicts outcome of neuroblastoma irrespective of MYCN amplification
…, JJ Molenaar, J van Nes… - Proceedings of the …, 2012 - National Acad Sciences
Neuroblastoma is a pediatric tumor of the sympathetic nervous system. MYCN (V-myc
myelocytomatosis viral-related oncogene, neuroblastoma derived [avian]) is amplified in 20% of …
myelocytomatosis viral-related oncogene, neuroblastoma derived [avian]) is amplified in 20% of …
[HTML][HTML] The immune landscape of neuroblastoma: challenges and opportunities for novel therapeutic strategies in pediatric oncology
…, A Künkele, S Nierkens, JJ Molenaar - European journal of …, 2021 - Elsevier
Immunotherapy holds great promise for the treatment of pediatric cancers. In neuroblastoma,
the recent implementation of anti-GD2 antibody Dinutuximab into the standard of care has …
the recent implementation of anti-GD2 antibody Dinutuximab into the standard of care has …